Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 18Colonic Neoplasms 4Rectal Neoplasms 2Neoplasm Metastasis 2Stomach Neoplasms 1Solid Tumor Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Metastatic Gastric Adenocarcinoma 1HER2 IHC3+ Advanced Colorectal Cancer 1Gastric and Gastroesophageal Junction Adenocarcinoma 1Carcinoma 1Advanced/Metastatic Solid Tumors 1Advanced Gastric Cancer 1Adenocarcinoma 1

Interventions

apatinib 2trifluridine tipiracil drug combination 1tipiracil 1Trifluridine 1SHR-1701 1Paclitaxel 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Gastric Cancer × Trifluridine × 1 year × Clear all
NCT07371871 2026-01-28

A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

Anhui Provincial Cancer Hospital

Phase NA Not yet recruiting
30 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡